Vijay Rajaram More

Vijay Rajaram More

Active Director Director DIN 08072299
DIN 08072299 First appointment Feb 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value •••• Premium profile

About Vijay Rajaram More

Data last updated:

Vijay Rajaram More is a Director at Wrightpharm Mediscinces Private Limited (since 2018). The company operates in Pharma. Wrightpharm Mediscinces Private Limited reported revenue of ₹30 Lakh (FY 2023).

DIN 08072299
Primary Designation Director
Industry Pharma
First Appointment 21 Feb 2018
Oldest Company Age 8 yrs
Largest company Wrightpharm Mediscinces Private Limited · ₹30 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Feb 20182018₹30 Lakh (FY 2023)Active

Board colleagues of Vijay Rajaram More

Directorship timeline

Open interactive timeline →
Wrightpharm Mediscinces Private Limited
Premium access

Shareholding and investment profile for Vijay Rajaram More

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Rajaram More

Vijay Rajaram More currently holds 1 directorship: Wrightpharm Mediscinces Private Limited (Director, since 21 Feb 2018, revenue ₹30 Lakh (FY 2023)).

Vijay Rajaram More was first appointed on 21 Feb 2018 as Director at Wrightpharm Mediscinces Private Limited.

The current boards of Vijay Rajaram More's companies include Tejaswini Abasaheb Bhosale (Wrightpharm Mediscinces Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available